Regulatory Solutions

81. Balancing Compliance Among The Shifting Sands Of Pharmaceutical Data Privacy Regulations 8/26/2022

    Maximize compliance, increase revenue potential, and improve patient safety by leveraging proven technology.

82. Bring More Confidence To Your Post-Marketing Pharmacovigilance And Safety Surveillance 8/1/2022

    Discover our records of success in PV excellence and experience so you can have certainty that our team will address your PV needs comprehensively and proficiently.

83. The Importance Of A Trusted Pharmacovigilance Partner 8/1/2022

    Veristat supports successful post-marketing pharmacovigilance (PV) expertise for pharmaceutical drugs, biologics, natural health products, and medical devices.

84. TrialScope Disclosure Services 9/27/2021

    Whether you’re conducting 10 or 1,000 trials, that can mean juggling disclosure submissions for multiple registries. TrialScope Disclosure Services — protocol registration, results disclosure, plain language summaries, and redaction — make compliance manageable.

85. Pharmacovigilance And Safety Surveillance 4/24/2021

    Delivering safety surveillance before and after regulatory approval for pre-approval and marketed health products.

86. TrialScope Global Disclosure Compliance Overview 11/4/2020

    Global clinical trial disclosure poses a challenge for many sponsors due to disparate tracking tools, teams located around the world and constantly changing regulations. However, sponsors can reduce risk with real-time access, metrics and answers.

87. Ten Big Questions To Ask Your Clinical Transparency Solution Partner 10/3/2018

    When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.

88. TrialScope Disclosure Management Brochure 9/24/2018

    TrialScope Disclose delivers the proven solutions clinical trial sponsors need to centralize, track, register, and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.

89. SMART First Human Dose (FHD)

    A CDMO with the right team of experts can aid drug development, regulatory compliance, and clinical trial supply, accelerating timelines to first human dose clinical trials and the path to market.

90. Early Development And Innovation

    Where better medicines begin

    Early phase decisions are mission critical to the long-term success of your promising innovations. Learn how Parexel’s multi-disciplinary early phase approach can bolster your clinical evidence, accelerate the path to proof of concept and reduce the white space between early and late phase development, so you can deliver high impact therapies to patients sooner.